IGG SUBCLASSES IN VARICELLA-ZOSTER VIRUS-INFECTIONS

被引：3
|
作者：
THOMAS, HIJ [1 ]
MORGANCAPNER, P [1 ]
MEURISSE, EV [1 ]
机构：
[1] ROYAL PRESTON HOSP,DEPT VIROL,POB 202,SHAROE GREEN LANE,PRESTON PR2 4HG,ENGLAND
来源：
SERODIAGNOSIS AND IMMUNOTHERAPY IN INFECTIOUS DISEASE | 1990年 / 4卷 / 05期
关键词：
IGG SUBCLASSES; VARICELLA; ZOSTER;
D O I：
10.1016/0888-0786(90)90028-M
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Sera from cases of varicella and zoster together with sera from healthy people seropositive for varicella-zoster virus (VZV) have been examined for their specific IgG subclass profile. Specific IgG1 was present in all sera containing VZV-specific IgG antibody. Sera from healthy individuals seropositive for VZV also commonly contained specific IgG2, IgG3 and IgG4. Specific IgG1 and IgG3 were the main subclasses detected after varicella in sera taken up to 2 months after the onset of symptoms. Specific IgG3 was also detected soon after zoster, but did not persist for as long as after varicella. Specific IgG2 and IgG4 can also be detected frequently after zoster, but rarely in the 2 months after varicella. Thus the IgG subclass profiles can be of some help in serologically distinguishing between varicella and zoster but cannot be used as the sole discriminatory factor. © 1990.
引用
收藏
页码：379 / 385
页数：7
相关论文
共 50 条
  • [21] Prospective surveillance of varicella-zoster virus infections in an out-patient setting in Switzerland
    Iseli, Andrea
    Aebi, Christoph
    Banz, Kurt
    Brunner, Matthias
    Schmutz, Andre M.
    Heininger, Ulrich
    HUMAN VACCINES, 2009, 5 (12): : 843 - 846
  • [22] Varicella-Zoster Virus Infections in Pediatric Malignancy Patients: A Seven-Year Analysis
    Duzgol, Mine
    Ozek, Gulcihan
    Bayram, Nuri
    Oymak, Yesim
    Kara, Ahu
    Demirag, Bengu
    Karapinar, Tuba Hilkay
    Ay, Yilmaz
    Vergin, Canan
    Devrim, Ilker
    TURKISH JOURNAL OF HEMATOLOGY, 2016, 33 (04) : 346 - 348
  • [23] Fatal varicella due to the vaccine-strain varicella-zoster virus
    Leung, Jessica
    Siegel, Subhadra
    Jones, James F.
    Schulte, Cynthia
    Blog, Debra
    Schmid, D. Scott
    Bialek, Stephanie R.
    Marin, Mona
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2014, 10 (01) : 146 - 149
  • [24] PREVENTION OF FETAL AND NEONATAL TRANSMISSION OF THE VARICELLA-ZOSTER VIRUS
    HADDAD, J
    GUT, JP
    LOKIEC, F
    PATHOLOGIE BIOLOGIE, 1992, 40 (07): : 724 - 728
  • [25] A Literature Review Regarding the Management of Varicella-Zoster Virus
    Bond, Deborah
    Mooney, Janice
    MUSCULOSKELETAL CARE, 2010, 8 (02) : 118 - 122
  • [26] Clinicopathologic understanding and control of varicella-zoster virus infection
    Asano, Yoshizo
    VACCINE, 2008, 26 (50) : 6487 - 6490
  • [27] Seroprevalence of Varicella-Zoster virus IgG antibodies in Swiss children during the first 16 months of age
    Heininger, U
    Desgrandchamps, D
    Schaad, UB
    VACCINE, 2006, 24 (16) : 3258 - 3260
  • [28] Natural varicella-zoster virus reactivation shortly after varicella immunization in a child
    Kohl, S
    Rapp, J
    La Russa, P
    Gershon, AA
    Steinberg, SP
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1999, 18 (12) : 1112 - 1113
  • [29] Varicella-Zoster Virus Myocarditis: Early Clinical Diagnosis and Outcome
    Cherukuri, Akhila Sai Sree
    Belay, Naod F.
    Nasereldin, Duaa S.
    Mohammed, Doaa O.
    Mohamed, Suzan
    Elkhazeen, Abuzar
    Ghobriel, Naglaa G.
    Alatta, Lina
    Alsafi, Wail
    Abdalla, Yaseen
    Brry, Gamila
    Abdelrahman, Nadir
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (04)
  • [30] Herpes simplex virus, varicella-zoster virus and cytomegalovirus keratitis: Facts for the clinician
    Labetoulle, Marc
    Boutolleau, David
    Burrel, Sonia
    Haigh, Oscar
    Rousseau, Antoine
    OCULAR SURFACE, 2023, 28 : 336 - 350
12345